IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NQ Hcif GP, Ltd.

Q3 2015 Holdings

Filed 2015-10-13 | 1 holdings | $92.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics Inc(RVNCEUR)COM761330109$92.2K3,096,650100.0%